Strand Therapeutics
Boston, United States · Founded 2017 · $153.0M raised
- Headquarters
- Boston
- Employees
- 51–200
- Founded
- 2017
- Business Model
- B2B
- Total Funding
- $153.0M
- Last Round
- $153.0M Series BAug 2025
- Rounds
- 1
About
Strand Therapeutics is a clinical-stage, Boston-based biotechnology company leading the genetic medicine revolution, founded in 2017 by MIT biological engineers Jake Becraft and Tasuku Kitada, who created the first mRNA programming language. The company has taken complex, programmable mRNA medicines from design through manufacturing to patients, building a pipeline of next-generation therapeutics for cancers and autoimmune disease. Strand's interdisciplinary team is now developing new delivery systems for tissues across the body so genetic medicines can reach more patients.
Summary
Strand Therapeutics is a Biotech company based in Boston, United States, founded in 2017. It has raised $153.0M in total across 1 round, most recently a $153.0M Series B round in Aug 2025. Investors include Kinnevik, Regeneron Ventures and ICONIQ Capital.
Funding History
Aug 2025
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/strand-therapeutics"><img src="https://indexed.vc/api/badge/company/strand-therapeutics" alt="Strand Therapeutics on Indexed.vc" width="260" height="76" /></a>